Parabilis Medicines, Inc.
PBLS- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001657677
In the last 90 days, Parabilis Medicines, Inc. insiders filed 1 open-market purchase and 0 sales; 79 institutions reported holding it in 13F filings for Q2 2026, worth $2.71B in total; no superinvestor holds it.
Superinvestors holding PBLS, Q2 2026
No superinvestor reported holding PBLS in Q2 2026.